Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone

Background: A systemic immune-inflammation index (SII) based on neutrophil (N), lymphocyte (L), and platelet (P) counts has shown a prognostic impact in several solid tumors. The aim of this study is to evaluate the prognostic role of SII in metastatic castration-resistant prostate cancer (mCRPC) pa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Lolli, Cristian, Caffo, Orazio, Scarpi, Emanuela, Aieta, Michele, Conteduca, Vincenza, Maines, Francesca, Bianchi, Emanuela, Massari, Francesco, Veccia, Antonello, Chiuri, Vincenzo E., Facchini, Gaetano, De Giorgi, Ugo
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2016
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5062111/
https://ncbi.nlm.nih.gov/pubmed/27790145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00376
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars